Nicardipine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 14 USDMF, 1 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

61 FDF Dossiers, 45 FDA Orange Book, 6 Europe, 10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 26 Coating Systems & Additives, 23 Direct Compression, 17 Thickeners and Stabilizers, 15 Controlled & Modified Release, 14 Taste Masking, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Film Formers & Plasticizers, 11 Granulation, 9 Disintegrants & Superdisintegrants, 8 Empty Capsules, 7 Chewable & Orodispersible Aids, 7 Parenteral, 5 Solubilizers, 4 Emulsifying Agents, 4 Topical, 3 Coloring Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 Finished Drug Prices

7 Finished Drug Prices

MARKET PLACE

17 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19734 / DOSAGE - INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NICARDIPINE HYDROCHLORIDE(UNII: K5BC5011K3) (NICARDIPINE - UNII:CZ5312222S)	NICARDIPINE HYDROCHLORIDE	0.1mg in 1 \| 0.1mg in 1

Inactive Ingredients

Ingredient Name	Chiesi USA, Inc.	EKR Therapeutics	EKR Therapeutics, Inc.
CITRIC ACID MONOHYDRATE(2968PHW8QP)
DEXTROSE MONOHYDRATE(LX22YL083G)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)
SORBITOL(506T60A25R)

Drug Product Composition: Nicardipine Hydrochloride